Cargando…
Outcome of thyroid associated ophthalmopathy treated by radiation therapy
Thyroid associated orbitopathy is a common manifestation of Graves disease. Many options can be considered for treatment. In this case series, we reviewed the medical records of 17 patients who received radiation therapy (RT) for GO in a tertiary care center between 1997 and 2007. All patients recei...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108307/ https://www.ncbi.nlm.nih.gov/pubmed/21569461 http://dx.doi.org/10.1186/1748-717X-6-46 |
_version_ | 1782205302972612608 |
---|---|
author | Abboud, Mirna Arabi, Asma Salti, Ibrahim Geara, Fady |
author_facet | Abboud, Mirna Arabi, Asma Salti, Ibrahim Geara, Fady |
author_sort | Abboud, Mirna |
collection | PubMed |
description | Thyroid associated orbitopathy is a common manifestation of Graves disease. Many options can be considered for treatment. In this case series, we reviewed the medical records of 17 patients who received radiation therapy (RT) for GO in a tertiary care center between 1997 and 2007. All patients received 20 Gy to both orbits and 12 of them (71%) had already received one or more trials of steroid therapy prior to RT. After a median follow-up of 2 years, a subjective improvement in exophthalmos and vision was reported by all patients at the end of RT but only 3 patients reported a decrease in their diplopia immediately after therapy. Symptoms continued to improve with time in many patients: 22% had complete reversal of their symptoms and signs, and the remaining 78% had partial improvement. Two patients developed recurrent signs and symptoms, both of them were smokers who continued to smoke after treatment. About 60-65% of patients responded favorably to RT alone which increased to 87-97% when RT is combined with steroids. No patients developed late toxicity during the follow-up period. We conclude that RT is an effective treatment option in GO even in patients who failed previous treatment with steroids or surgical decompression. Based on our own clinical experiences and the literature data, the combination of RT and intravenous corticosteroid administration may improve the response rate. |
format | Online Article Text |
id | pubmed-3108307 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31083072011-06-07 Outcome of thyroid associated ophthalmopathy treated by radiation therapy Abboud, Mirna Arabi, Asma Salti, Ibrahim Geara, Fady Radiat Oncol Short Report Thyroid associated orbitopathy is a common manifestation of Graves disease. Many options can be considered for treatment. In this case series, we reviewed the medical records of 17 patients who received radiation therapy (RT) for GO in a tertiary care center between 1997 and 2007. All patients received 20 Gy to both orbits and 12 of them (71%) had already received one or more trials of steroid therapy prior to RT. After a median follow-up of 2 years, a subjective improvement in exophthalmos and vision was reported by all patients at the end of RT but only 3 patients reported a decrease in their diplopia immediately after therapy. Symptoms continued to improve with time in many patients: 22% had complete reversal of their symptoms and signs, and the remaining 78% had partial improvement. Two patients developed recurrent signs and symptoms, both of them were smokers who continued to smoke after treatment. About 60-65% of patients responded favorably to RT alone which increased to 87-97% when RT is combined with steroids. No patients developed late toxicity during the follow-up period. We conclude that RT is an effective treatment option in GO even in patients who failed previous treatment with steroids or surgical decompression. Based on our own clinical experiences and the literature data, the combination of RT and intravenous corticosteroid administration may improve the response rate. BioMed Central 2011-05-13 /pmc/articles/PMC3108307/ /pubmed/21569461 http://dx.doi.org/10.1186/1748-717X-6-46 Text en Copyright ©2011 Abboud et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Report Abboud, Mirna Arabi, Asma Salti, Ibrahim Geara, Fady Outcome of thyroid associated ophthalmopathy treated by radiation therapy |
title | Outcome of thyroid associated ophthalmopathy treated by radiation therapy |
title_full | Outcome of thyroid associated ophthalmopathy treated by radiation therapy |
title_fullStr | Outcome of thyroid associated ophthalmopathy treated by radiation therapy |
title_full_unstemmed | Outcome of thyroid associated ophthalmopathy treated by radiation therapy |
title_short | Outcome of thyroid associated ophthalmopathy treated by radiation therapy |
title_sort | outcome of thyroid associated ophthalmopathy treated by radiation therapy |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108307/ https://www.ncbi.nlm.nih.gov/pubmed/21569461 http://dx.doi.org/10.1186/1748-717X-6-46 |
work_keys_str_mv | AT abboudmirna outcomeofthyroidassociatedophthalmopathytreatedbyradiationtherapy AT arabiasma outcomeofthyroidassociatedophthalmopathytreatedbyradiationtherapy AT saltiibrahim outcomeofthyroidassociatedophthalmopathytreatedbyradiationtherapy AT gearafady outcomeofthyroidassociatedophthalmopathytreatedbyradiationtherapy |